Last update:
Oncology news
New AI tool helps scientists see how cells work together inside diseased tissue
Doctors and scientists have long relied on microscopes to study human tissue and diagnose disease. But today's medical research produces far more information than the human eye alone can handle, including detailed maps of ...
8 hours ago
0
0
Doctors discover a simple method to predict the risk of brain tumor recurrence
Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the meninges, the membranes that surround the brain. In most cases, a meningioma is benign. However, ...
8 hours ago
0
0
HPV cancer vaccine slows tumor growth and extends survival in preclinical model
Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: Performance depends not only on vaccine components but also on vaccine structure. After proving this concept ...
10 hours ago
0
13
A single oncolytic virus injection may help T cells infiltrate glioblastoma
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can ...
13 hours ago
0
48
Tiny worm offers clues to combat chemotherapy neurotoxicity
Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant long-term side effects that can dramatically affect patients' quality of life. Among the most debilitating ...
14 hours ago
0
45
Key gene behind drug resistance in small cell lung cancer identified
A research team has discovered a crucial mechanism that underlies chemotherapy resistance and metastasis in small cell lung cancer (SCLC). Their study shows that the silencing of the RASA4 gene through epigenetic mechanisms ...
14 hours ago
0
0
Aggressive brain tumors build protective 'sugar shield' to survive extreme stress
For the first time, researchers have identified a previously unrecognized metabolic defense mechanism in aggressive brain tumors: a sugar-rich shield that surrounds tumor cells and protects them against a particularly destructive ...
15 hours ago
0
0
Established cancer drug can reactivate immunotherapy
Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune cells recognize gradually ...
15 hours ago
0
0
Molecule found to drive skin cancer growth and evade immune detection
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade attack by the body's immune system, a new study shows. Led by researchers at NYU Langone Health and ...
8 hours ago
0
0
Clinical practice guidelines on frontline and relapsed/refractory management published
The American Society of Hematology (ASH) released guidelines on frontline management of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs), as well as the management of relapsed or refractory disease ...
2 hours ago
0
0
Review calls for risk-based screening as never-smoker lung cancers rise
Lung cancer patients who have never smoked make up a significant and growing share of global lung cancer cases, yet remain an understudied group, according to a new review written by UCL (University College London) researchers.
13 hours ago
0
0
Experimental drug may protect the brain against depression and cognitive impairment caused by whole brain radiotherapy
Whole brain radiotherapy (WBRT) saves lives by treating cancer that has spread to the brain, but it also causes long-standing brain damage. Many patients who go through radiation treatment later develop memory problems, thinking ...
7 hours ago
0
0
Proton therapy leads to positive survival and quality of life outcomes for patients with lower grade glioma
A study by investigators from Mass General Brigham Cancer Institute evaluates the efficacy and safety of proton therapy for patients with lower grade gliomas (LGGs). The single-arm prospective phase 2 trial results demonstrated ...
9 hours ago
0
0
Potential immune evasion mechanism identified in premalignant lung lesions
Throughout a person's lifetime, the cells lining the respiratory tract are exposed to inhaled pollutants, including cigarette smoke. These exposures can cause molecular changes that disrupt normal cell behavior, leading to ...
10 hours ago
0
0
Harnessing antiviral memory to fight tumors: Redirected antibodies show promise
Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do not trigger especially ...
21 hours ago
0
0
Investigators study ivermectin's 'ability to kill cancer cells'
The National Cancer Institute, the federal research agency charged with leading the war against the nation's second-largest killer, is studying ivermectin as a potential cancer treatment, according to its top official.
17 hours ago
0
0
Rural cancer patients do just as well when having surgery close to home
Adults living in rural communities often travel long distances when seeking treatment for cancer, but distant travel may not always be necessary to receive high-quality surgical care, according to a new analysis published ...
15 hours ago
0
0
Study finds immune markers at two months tied to longer survival in glioblastoma trial
Researchers at The University of Texas MD Anderson Cancer Center have identified blood-based biomarkers that can help distinguish patients with glioblastoma who are most likely to live longer from novel treatment with an ...
17 hours ago
0
0
DNA barcoding reveals the complexity of breast cancer liquid biopsies
Australian scientists have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and treatment strategies. The ...
19 hours ago
0
0
Does a past abortion or miscarriage affect a woman's risk of developing breast cancer?
A prior abortion or miscarriage was not linked with an increased risk of developing pre- or postmenopausal breast cancer in a study published in Acta Obstetricia et Gynecologica Scandinavica.
21 hours ago
0
20
Growth of spreading pancreatic cancer is fueled by 'underappreciated' epigenetic changes, shows study
In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns Hopkins Medicine scientists report they have found that a gene called KLF5 (Krueppel-like factor ...
Feb 10, 2026
0
37
Combination treatment may slow disease progression in advanced sarcoma
An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology. "These findings support ...
Feb 10, 2026
0
0
Discovery of unique brain tumor subtypes offers hope for targeted glioma therapies
Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, explain why patients respond ...
Feb 10, 2026
0
0
Ovarian cancer cells surprise scientists—the body's own defense may be the key to longer survival
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to stronger immune responses ...
Feb 10, 2026
0
0
Investigating the use of a common vitamin to treat the aggressive brain cancer glioblastoma
Edward (Ed) Waldner had no idea why he didn't feel well, but he knew he didn't feel like himself. At 55 years of age, he felt exhausted all the time. It didn't seem to matter how hard he had worked that day. He wondered if ...
Feb 10, 2026
0
15
